K. R. Read
Impact in
-
- Research on Leishmaniasis Studies
- Epidemiology top 2%
- Trypanosoma species research and implications
Papers in
-
- Research on Leishmaniasis Studies 24
- Epidemiology 31
- Trypanosoma species research and implications 31
- Co-authors
- Alan H. Fairlamb (13 shared papers)Ian Hugh Gilbert (23 shared papers)Susan Wyllie (9 shared papers)Paul Graham Wyatt (16 shared papers)Suzanne Norval (15 shared papers)Manu De Rycker (7 shared papers)Laste Stojanovski (14 shared papers)Stephen Patterson (5 shared papers)
- Journals
- Journal of Medicinal Chemistry (8 papers)ChemMedChem (6 papers)Nature Communications (3 papers)Drug Metabolism and Disposition (3 papers)Journal of Pharmacology and Experimental Therapeutics (3 papers)
- Partner nations
- United KingdomSwitzerlandAustralia
In The Last Decade
K. R. Read
74 papers receiving 3.2k citations
K. R. Read's Hit Papers
Peers
Comparison fields: 5 of 120
- Public Health, Environmental and Occupational Health 1.0k
- Epidemiology 1.1k
- Toxicology 92
- Organic Chemistry 797
- Parasitology 158
Countries citing papers authored by K. R. Read
This map shows the geographic impact of K. R. Read's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. R. Read with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. R. Read more than expected).
Fields of papers citing papers by K. R. Read
This network shows the impact of papers produced by K. R. Read. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. R. Read. The network helps show where K. R. Read may publish in the future.
Co-authors
The 25 scholars most cited alongside K. R. Read, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need Hit paper breakdown → | 2017 | 329 |
| 2 | 2007 | 246 | |
| 3 | 2016 | 189 | |
| 4 | 2012 | 134 | |
| 5 | 2017 | 129 | |
| 6 | 2022 | 119 | |
| 7 | 2010 | 109 | |
| 8 | 2011 | 98 | |
| 9 | 2009 | 96 | |
| 10 | 2008 | 89 | |
| 11 | 2011 | 86 | |
| 12 | 2016 | 73 | |
| 13 | 2016 | 69 | |
| 14 | 2016 | 66 | |
| 15 | 2008 | 60 | |
| 16 | 2010 | 58 | |
| 17 | 2013 | 57 | |
| 18 | 2010 | 55 | |
| 19 | 2020 | 55 | |
| 20 | 2012 | 52 |
About K. R. Read
K. R. Read is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology, Organic Chemistry, Molecular Biology and Computational Theory and Mathematics, having authored 76 papers that have together received 3.3k indexed citations. Recurring topics across this work include Trypanosoma species research and implications (31 papers), Research on Leishmaniasis Studies (24 papers), Synthesis and Biological Evaluation (16 papers), Computational Drug Discovery Methods (9 papers), Drug Transport and Resistance Mechanisms (8 papers), Biochemical and Molecular Research (6 papers), Ubiquitin and proteasome pathways (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). The work is most often cited by research in Public Health, Environmental and Occupational Health (1.0k citations), Epidemiology (1.1k citations), Toxicology (92 citations), Organic Chemistry (797 citations) and Parasitology (158 citations). K. R. Read has collaborated with scholars based in United Kingdom, Switzerland and Australia. Frequent co-authors include Alan H. Fairlamb, Ian Hugh Gilbert, Susan Wyllie, Paul Graham Wyatt, Suzanne Norval, Manu De Rycker, Laste Stojanovski, Stephen Patterson, David Horn and Phil Jeffrey. Their work appears in journals such as Journal of Medicinal Chemistry, ChemMedChem, Nature Communications, Drug Metabolism and Disposition and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.